Related Experiment Videos
In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to cefmetazole
Antimicrobial Agents and Chemotherapy
|February 1, 1985
Abstract:
The in vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to cefmetazole was studied by the agar dilution method. At a concentration of 16 micrograms/ml or lower, 44 isolates (96%) of M. fortuitum and 8 isolates (40%) of M. chelonei were inhibited.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Ultra minimally invasive sonographically guided carpal tunnel release: an external pilot study.
Orthopaedics & traumatology, surgery & research : OTSR·2014
[Antimicrobial susceptibility of Enterococcus faecalis isolated from patients in Córdoba (Spain)].
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2006
[Antimicrobial susceptibility of bacterial isolates from patients with cystic fibrosis].
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2005
Investigation of biological risk in mycobacteriology laboratories: a multicentre study.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2003
Comparison of susceptibility testing of Mycobacterium tuberculosis using the ESP culture system II with that using the BACTEC method.
Journal of clinical microbiology·2000
[Comparative study of three systems for in vitro activity investigation of fluconazole against yeast isolates of clinical interest].
Enfermedades infecciosas y microbiologia clinica·1999
OT-CATH, a conserved antimicrobial peptide in Otariidae species, exhibits potent activity against gram-negative bacteria.
Antimicrobial agents and chemotherapy·2026
Pulmonary pharmacokinetics and lesion penetration of antimicrobials in patients with nontuberculous mycobacterial disease.
Antimicrobial agents and chemotherapy·2026
G-quadruplex-binding ligand RHPS4 reduces Plasmodium falciparum mitochondrial DNA level providing a novel antimalarial strategy.
Antimicrobial agents and chemotherapy·2026
Anti-plasmodial activity of proteasome inhibitors against various Plasmodium species: a preclinical evaluation.
Antimicrobial agents and chemotherapy·2026